申请人:Memorial Sloan-Kettering Cancer Center
公开号:US11180492B2
公开(公告)日:2021-11-23
The present disclosure provides compounds of Formula (I′), Formula (II), and Formula (III). The compounds described herein may useful in treating and/or preventing protozoan infections in a subject in need thereof, treating and/or preventing trypanosomal infections (e.g., Trypanosoma cruzi (T. cruzi) or Trypanosoma brucei infections) and/or plasmodial infections in a subject in need thereof, treating and/or preventing diseases in a subject in need thereof (e.g., Chagas disease, malaria, and/or sleeping sickness), and may be useful in treating and/or preventing infectious diseases in a subject in need thereof. Also provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including a compound described herein.
本公开提供了式(I′)、式(II)和式(III)化合物。本文所述化合物可用于治疗和/或预防有需要的受试者的原生动物感染,治疗和/或预防有需要的受试者的锥虫感染(如克鲁斯锥虫(T.cruzi)或布鲁西锥虫感染)和/或浆细胞感染,治疗和/或预防有需要的受试者的疾病(如恰加斯病、疟疾和/或昏睡病),并可用于治疗和/或预防有需要的受试者的传染性疾病。本公开还提供了包括本文所述化合物的药物组合物、试剂盒、方法和用途。